Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

Researchers have identified a group of brain cells in mice that play a key role in regulating appetite. These neurons, ...

The eye does not have a way to remove floaters, so you will have them as long as you live unless you do something about it.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

There's growing evidence to suggest that GLP-1 drugs, which include Ozempic's semaglutide, may be useful for treating alcohol ...

“The first thing they see is the loose skin on their abdomen," says R. Brannon Claytor, a Bryn Mawr, Pa.-based plastic ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.